Echo IQ (ASX:EIQ)

It's all happening stateside! Hot on the trail of our FDA approval ✅, Echo IQ (ASX:EIQ) is hiring our first US based Clinical Application Specialist role to help deliver EchoSolv™ into health care systems 🏥! If you, or a member of your network are passionate about bringing lifesaving AI and new cardiovascular disease detection 🫀 capabilities into existing cardiology workflows, we want to hear from you! #aiwithheart #cardiology #heartdisease #PACS #DICOM #CardiologyReporting

Huge congratultaions to Dr Philippe Généreux, MD and his research team on this pivotal study that demonstrated the significant benefits of treating asymptomatic aortic stenosis patients with TAVR. Change is often achieved by those brave enough to challenge the status quo!

From January 2025, Echo IQ will have a new CEO leading the charge. The Board of Echo IQ welcomes Dustin Haines to the role. Dustin will be US-based, spearheading our commercial expansion. #aiforhealth, #echocardiology, #healthcare, #medicaltechnology

We are thrilled to announce that our AI-solution for severe Aortic Stenosis, EchoSolv-AS, has been cleared by the US FDA. This is a significant milestone in our development and one we are extremely proud of. We look forward to rolling out this innovative technology and thank our many colleagues, partners and contributors who helped make this possible. Dane Brescacin, Don Fowler, Geoff Strange, David Playford, Deon Strydom, Seán Bryceland

As we acknowledge World Heart Day 2024, we celebrate the great advances in medical technology bringing new treatments to those who need them most. Echo IQ is proud to be contributing to this changing landscape. #aiwithheart #aiforgood #aiforhealth

Earlier today, leading journal, JACC Advances (from the American College of Cardiology), published extensive results from our clinical cohort study that examined how well Echo IQ's artificial intelligence algorithm could detect patients with severe aortic stenosis, as well as those with a similar mortality risk despite not meeting current clinical guidelines for that severity of disease. These strong results show significant numbers of patients, now easier to identify, who might benefit from further review and closer attention. Congratulations to our colleagues Geoff Strange and David Playford, and to Jordan Strom and Simon Stewart on this achievement. To read more, please go to: https://lnkd.in/du9pBq-z #cardiology, #echocardiology, #aiforgood

We’re #hiring. Echo IQ is looking to add a US-based Marketing Director to join our growing team. Know anyone who might be interested? Get in touch with Deon Strydom.

Echo IQ features in not one, but TWO, late-breaking science presentations at the European Society of Cardiology's #ESCCongress in London this week. Check out Simon Stewart's presentation later today as he talks about rapid detection of heart failure using artificial intelligence. It's a game changer. Deon Strydom, David Playford, Dane Brescacin, Geoff Strange, Don Fowler

If you're in London for #ESCCongress this year, make sure you check out Geoff Strange giving his late-breaking science presentation on AI for heart failure. It should be exciting. You can hear him Friday at 14:10 in the Bern room! European Society of Cardiology, Deon Strydom, David Playford

Echo IQ recently featured in the 180 Markets "18 Minutes with.." series. Check out Deon Strydom and Geoff Strange in conversation as they talk about our progress in delivering innovative new AI-backed solutions for cardiology.